BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12835568)

  • 1. Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma.
    Calikoglu E; Chavaz P; Saurat JH; Kaya G
    Dermatology; 2003; 207(1):104-6. PubMed ID: 12835568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronate accumulation and decreased CD44 expression in perifollicular solitary cutaneous myxoma.
    Calikoglu E; Augsburger E; Masouyé I; Chavaz P; Saurat JH; Kaya G
    Dermatology; 2002; 205(2):122-6. PubMed ID: 12218225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and hyaluronate expression in follicular mucinosis.
    Kaya G; Augsburger E; Chavaz P; Saurat JH
    J Cutan Pathol; 2006 Mar; 33(3):227-30. PubMed ID: 16466510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus et atrophicus.
    Kaya G; Augsburger E; Stamenkovic I; Saurat JH
    J Invest Dermatol; 2000 Dec; 115(6):1054-8. PubMed ID: 11121141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E; Augsburger E; Chavaz P; Saurat JH; Kaya G
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoid dermatofibroma on a great toe: a case report.
    Moon A; Yoon N; Kim HS
    Int J Clin Exp Pathol; 2015; 8(6):7605-9. PubMed ID: 26261677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoid dermatofibroma.
    Zelger BG; Calonje E; Zelger B
    Histopathology; 1999 Apr; 34(4):357-64. PubMed ID: 10231403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD99 expression in dermatofibrosarcoma protuberans and dermatofibroma.
    Kazlouskaya V; Malhotra S; Kabigting FD; Lal K; Elston DM
    Am J Dermatopathol; 2014 May; 36(5):392-6. PubMed ID: 24247571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ; Fekete E; From L
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined dermatofibroma: co-existence of two or more variant patterns in a single lesion.
    Zelger BG; Sidoroff A; Zelger B
    Histopathology; 2000 Jun; 36(6):529-39. PubMed ID: 10849095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer.
    Auvinen P; Tammi R; Kosma VM; Sironen R; Soini Y; Mannermaa A; Tumelius R; Uljas E; Tammi M
    Int J Cancer; 2013 Feb; 132(3):531-9. PubMed ID: 22753277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxofibrosarcoma presenting in the skin: clinicopathological features and differential diagnosis with cutaneous myxoid neoplasms.
    Mansoor A; White CR
    Am J Dermatopathol; 2003 Aug; 25(4):281-6. PubMed ID: 12876484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myxoid atypical fibroxanthoma: a previously undescribed variant.
    Patton A; Page R; Googe PB; King R
    J Cutan Pathol; 2009 Nov; 36(11):1177-84. PubMed ID: 19320792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal accumulation of inter-alpha-trypsin inhibitor and hyaluronic acid in lichen sclerosus.
    Kuroda K; Fujimoto N; Tajima S
    J Cutan Pathol; 2005 Feb; 32(2):137-40. PubMed ID: 15606672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibroma with myxoid changes in a patient with psoriasis.
    Yamamoto T; Yokoyama A; Katayama I; Nishioka K
    J Dermatol; 1995 Oct; 22(10):780-3. PubMed ID: 8586761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotic fibroma-like dermatofibroma: an uncommon distinctive variant of dermatofibroma.
    González-Vela MC; Val-Bernal JF; Martino M; González-López MA; García-Alberdi E; Hermana S
    Histol Histopathol; 2005 Jul; 20(3):801-6. PubMed ID: 15944929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor alpha overexpression in multinucleate cell angiohistiocytoma: new insights into the pathogenesis of a reactive process.
    Cesinaro AM; Roncati L; Maiorana A
    Am J Dermatopathol; 2010 Oct; 32(7):655-9. PubMed ID: 20644465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibroma with granular cells: a report of two cases.
    Aloi F; Albertazzi D; Pippione M
    Dermatology; 1999; 199(1):54-6. PubMed ID: 10449959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans.
    Kubo M; Ihn H; Yamane K; Tamaki K
    Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatofibroma-a critical evaluation.
    Zelger B; Zelger BG; Burgdorf WH
    Int J Surg Pathol; 2004 Oct; 12(4):333-44. PubMed ID: 15494859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.